Skip to content

Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'

Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06731114
Enrollment
54
Registered
2024-12-12
Start date
2024-07-15
Completion date
2025-07-15
Last updated
2024-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicogenic Headache

Brief summary

This study is a randomised control trial and the purpose of this study is to determine the Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache.

Detailed description

Cervicogenic headache is a common headache that causes disability and affects everyday activities. Headache related disorders are the second most common reason for years lived with disability all over the world. According to the latest International Headache Society model, cervicogenicheadache (CGH) is a secondary headache having C1-C2 dysfunction. There is marked limitation in cervical ROM specially rotation. Treatment indicated involves use of electrotherapy and thermal modalities. In addition, use of different manual therapy techniques are advocated to eliminate the root cause i.e. C1-C2 dysfunction treating. patients with cervicogenic headache are mostly presented with forward head posture and weak deep neck flexors which may excerbate the headache symptoms.Therefore The purpose of this study is to determine the Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache

Interventions

Suboccipital muscle release.6 consecutive sessions for 2 weeks • Frequency:( 3mins 3 reps) 9 mins .12 sessions in total

PROCEDUREConventional physical therapy

TENS and hot pack for 10 mins 6 days a week for consecutive 2 weeks

Frequency: 5 mins of SCM release and 9 mins (3 mins 3 reps )of suboccipital release. 12 sessions in total.

Sponsors

Foundation University Islamabad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This is a randomized controlled trial having two groups.one group will recieve conventional physical therapy including hot pack and tens for 10mins and suboccipital muscle release ( 3mins 3 reps) 9 mins .12 sessions in total where as group B will receive Sternocleidomastoid release for 5 mins along with suboccipital muscle release and conventional physical therapy.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Participants will be included according to international classification of headache criteria which includes: * Headache with neck stiffness * Headache at least once a month in the last 3 months * Headache with at least 4 score in Numeric Pain Rating Scale(NPRS) * Unilateral headache with no shift of side * Positive flexion rotation test (Rotation restriction is greater than 10 degrees) * C1-C2 dysfunction * Headache precipitated by sustained neck movements,myofacial trigger points palpation in neck * Age group 18-45 * Both male and female

Exclusion criteria

* Cervical spondylosis * Headache of non-cervical origin * Dizziness or visual disturbance * Cervical radiculopathy/ nerve root involvement/ disc herniation * Cervical instability/ fracture * Vertebrobasilar insufficiency * Thoracic outlet syndrome * Cervical spine surgery * Cervical spondylolisthesis * Spinal infection or tumors * Osteoporosis * meningitis * subarachnoid hemorrhage

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensity2 weeksPain will be measured on the basis of Numeric Pain Rating Scale score.
ROM2 weeksCervical rotation will be measured through CROM device

Countries

Pakistan

Contacts

Primary ContactAyesha Arshad, MS-MSKPT
aesharshad4200@gmail.com03315314699

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026